logo Kompas.id
EnglishPharmaceuticals Affected by...
Iklan

Pharmaceuticals Affected by Rupiah Slump

The rupiah’s weakening against the United States dollar has affected the domestic pharmaceutical industry, which imports around 90 percent of its raw ingredients. The imports of raw ingredients had always burdened pharmaceutical company.

By
· 3 minutes read
https://cdn-assetd.kompas.id/Kw-_YIBEig5-BvdIJV2fjdx3lzw=/1024x651/filters:watermark(https://cdn-content.kompas.id/umum/kompas_main_logo.png,-16p,-13p,0)/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2018%2F09%2F20110502kuma.jpg
KOMPAS/HERU SRI KUMORO

Drugs are produced at a PT Kalbe Farma factory in Cikarang, Bekasi, West Java, on Monday (2/5/2011).

JAKARTA, KOMPAS – The rupiah’s weakening against the United States dollar has affected the domestic pharmaceutical industry, which imports around 90 percent of its raw ingredients.

Pharmaceutical company PT Dexa Medica director Gunawan Lukman said in Jakarta on Friday (7/9/2018) that imports of raw ingredients had always burdened his company. Nevertheless, he continued that Dexa would not take any strategic steps against the rupiah’s weakening. “We will observe how the [rupiah] exchange rate develops in the coming days. Currently, we are trying to increase our efficiency and not to immediately increase our prices,” he said.

Editor:
Share
Logo Kompas
Logo iosLogo android
Kantor Redaksi
Menara Kompas Lantai 5, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 5347 710
+6221 5347 720
+6221 5347 730
+6221 530 2200
Kantor Iklan
Menara Kompas Lantai 2, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 8062 6699
Layanan Pelanggan
Kompas Kring
+6221 2567 6000